(19)
(11) EP 2 035 829 A2

(12)

(88) Date of publication A3:
03.04.2008

(43) Date of publication:
18.03.2009 Bulletin 2009/12

(21) Application number: 07733193.2

(22) Date of filing: 13.06.2007
(51) International Patent Classification (IPC): 
G01N 33/50(2006.01)
G01N 33/68(2006.01)
 G01N 33/574(2006.01)
(86) International application number:
PCT/GB2007/002187
(87) International publication number:
WO 2007/144606 (21.12.2007 Gazette 2007/51)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 13.06.2006 GB 0611669

(71) Applicants:
  • AstraZeneca UK Limited
    London W1Y 1LK (GB)
  • Medical Proteoscope Co., Ltd.
    Nishi-shinjuku, Shijukuku Tokyo 163-0217 (JP)

(72) Inventors:
  • NISHIMURA, Toshihide
    Tokyo, 163-0217 (JP)
  • OGIWARA, Atsushi
    Tokyo, 163-0217 (JP)
  • KAWAMURA, Takeshi
    Tokyo 163-0217 (JP)
  • KAWAKAMI, Takao
    Tokyo, 163-0217 (JP)
  • KYONO, Yutaka
    Tokyo, 163-0217 (JP)
  • KANAZAWA, Mitsuhiro
    Tokyo 163-0217 (JP)
  • NYBERG, Fredrik
    SE-431 83 Mölndal (SE)
  • MARKO-VARGA, György
    S-221 87 Lund (SE)
  • ANYOJI, Hisase
    Tokyo, 163-0217 (JP)

(74) Representative: O'Brien, Simon Warwick et al
D Young & Co 120 Holborn
GB-London EC1N 2DY
GB-London EC1N 2DY (GB)

   


(54) MASS SPECTROMETRY BIOMARKER ASSAY